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Background
Drug-resistant HIV, a major global concern, warrants
the development of novel anti-virals as alternative and
inexpensive therapy. In the current study, we isolated
potentially drug-resistant HIV and assessed previously
unreported anti-viral activity of Jatropha curcas leaf
extracts.
Methods
In vitro micro-co-culture was employed for virus isola-
tion followed by drug susceptibility assays to determine
resistance to Azidothymidine (AZT) and Lamivudine
(3TC).
Jatropha curcasleaves were extracted using Soxhlet
apparatus. Methanolic (ME) and aqueous (AE) extracts
were chosen for further study. Secondary metabolites
were detected by High-Performance Thin Laye rChro-
matography and in vitro cytotoxicity established by
MTT assay. Anti-viral activity was evaluated by p24
inhibitionin post- and pre-infection interaction studies.
Results
Seven HIV isolates were obtained (isolation rate:
23.33%) with drug IC50 values ranging from 0.001418-
82.73 µM AZT and 2.645-15.35 µM 3TC.
Tannins, flavonoids, saponins were detected in AE and
flavonoids, saponins in ME while CC50 values were
32.07 mg/mL AE and 35.5 mg/mL ME.
In post-infection studies (4 isolates), IC50 values were
ranging from 0.0255-0.4137 mg/mL AE and 0.00073-
0.1278 mg/mL ME; pre-infection studies (1 isolate)
showed 100% p24 inhibition by ME and 97.19% p24
inhibition by AE at 25 mg/mL each.
Conclusion
HIV isolates potentially resistant to AZT/3TC were
obtained; genotypic drug resistance is being ascertained.
Jatropha curcas leaf extracts showed effective anti-viral
and probable entry inhibition activity against potentially
drug-resistant HIV, which has not been reported earlier.
We conclude that Jatropha curcasis a good candidate
for anti-HIV therapy with further research.
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